Skip to content
MarketScale
‹ Back to IndustriesHealthcare

i-FAB Awarded to Hindfoot Misalignment Research Study

Hindfoot malalignment is a major cause of pathology in the foot and ankle and impacts the biomechanics of these areas of the body. Standard 2D radiograph measurements are plagued by anatomical and operator bias due to inaccuracies with 2D plane projections. Weight Bearing Computed Tomography (WBCT) and semi-automated 3D measurements of the hindfoot have shown…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Hindfoot malalignment is a major cause of pathology in the foot and ankle and impacts the biomechanics of these areas of the body. Standard 2D radiograph measurements are plagued by anatomical and operator bias due to inaccuracies with 2D plane projections. Weight Bearing Computed Tomography (WBCT) and semi-automated 3D measurements of the hindfoot have shown promise for increased accuracy. They do have a critical shortcoming, however; they cannot offer information related to surface-to-surface interactions throughout various parts of the ankle and foot.

Sorin Siegler, Maui Jepsen, and Francois Lintz recently completed a study with the goal of addressing these inadequacies and finding solutions. They applied a 3D biometric tool based on distance mapping, which describes this interaction to WBCT data to characterize the effect of hindfoot valgus and varus deformities. 30 bilateral data sets were obtained, and the images were then processed to create 3D models of the foot and ankle structures. 3D CAD software calculated surface-to-surface interactions at various joints and created color-coded distance maps. The team then compared the images from the deformed feet to those of the normal feet.

With respect to hindfoot valgus, they discovered the antero-medial side of the talus is closer to the medial malleolus as this bone moves into slight external rotation and plantarflexion. The calcaneus is externally rotated relative to the talus, resulting in surface approximations on the lateral side of the posterior articular facet and an impingement of the sinus tarsi. In addition, a strong approximation on the superior side of the calcaneocuboid joint and the lateral side of the talonavicular joint occurs at the Chopart joint. At the cunei-navicular joint, there is a significant approximation of the lateral cuneiform to the navicular. At the metatarsal-cuneiform joints is a strong approximation at the 2nd and 3rd metatarsals joint surfaces.

In hindfoot varus, it was evident that the medial and lateral sides of the talus are closer to their respective malleoli, and anteromedial side of the talar dome approximates the tibial plafond, as the talus moves into inversion and slight dorsiflexion. The calcaneus is internally rotated and inverted relative to the talus, resulting in surface approximations on the medial side of the calcaneus bridging the gap between the posterior and middle articular facet and at the lateral side of the posterior articular facet of the calcaneus. The cuboid is displaced inferior to the navicular resulting in contact on the lateral facet of the calcaneocuboid joint. Also, a strong approximation at the talo-navicular joint can be observed on the medial side. At the cunei-navicular joint, the lateral cuneiform surface is displaced away from the navicular surface compared to normal.

It was concluded that WBCT can provide accurate classification of these foot and ankle deformities. Distance mapping allowed the team to characterize the specific surface-to-surface interactions at the joints and distinguish more readily between the hindfoot deformities. This information can be valuable in understanding certain pathologies associated with hindfoot varus and valgus deformities. In addition, the color-coded distance maps provided an effective method for assessing the effect of hindfoot deformities on articular joint surface interaction in the foot and ankle. The maps also enhance diagnostics, with future applications in evaluating therapy efforts to restore normal alignment.

Not only was this study highly successful in its future applications to diagnosing and treating these deformities, it also was the recipient of the distinguished i-FAB award. The mission of i-FAB, or International Foot and Ankle Biometrics Community, is to improve our understanding of foot and ankle mechanics as it applies to health, disease, and the design, development and evaluation of foot and ankle surgery, and interventions such as footwear and insoles/orthotics.

Learn about CurveBeam’s ongoing commitment to advancing foot and ankle care here.

Read more at curvebeam.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512